AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® …
6 days ago · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led …
Teva Real-World Study Finds AUSTEDO and AUSTEDO XR Improve Movement …
3 days ago · PARSIPPANY, N.J., and TEL AVIV, Israel – – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the …
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia …
1 day ago · Phase 4 data from Teva Pharmaceuticals on deutetrabenazine (Austedo) showed significant reduction in involuntary movement and improvements in quality of life in adults with …
Teva Pharmaceuticals Reports Positive Real-World Data on …
5 days ago · Teva Pharmaceuticals presented new findings from the IMPACT-TD Registry indicating that treatment with AUSTEDO and AUSTEDO XR significantly improved the lives of …
Teva Pharmaceuticals Industries Presents New Data From The …
5 days ago · Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of new data from the ongoing, real …
Teva (TEVA) Reveals Promising Data on AUSTEDO for Tardive …
5 days ago · Teva Pharmaceutical Industries' U.S. branch reveals promising results from the IMPACT-TD Registry for AUSTEDO tablets. Significant improvements in tardive dyskinesia …
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® …
5 days ago · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led …
Austedo medicine: Understanding its role in movement disorders
5 days ago · Austedo is a medication that has been gaining attention for its effectiveness in treating certain movement disorders. This article delves into what Austedo is, how it works, …
Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment …
Aug 20, 2021 · The findings, published online in The American Journal of Geriatric Psychiatry, evaluated the long-term use of AUSTEDO with the total motor Abnormal Involuntary …
Tevapharm - Movement Disorders
Teva is dedicated to advancing care and treatment options for those living with neurological movement disorders, particularly Huntington’s disease (HD) and tardive dyskinesia (TD).